Alexandre Charmillon

639 total citations
28 papers, 364 citations indexed

About

Alexandre Charmillon is a scholar working on Pharmacology, Applied Microbiology and Biotechnology and Epidemiology. According to data from OpenAlex, Alexandre Charmillon has authored 28 papers receiving a total of 364 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Pharmacology, 12 papers in Applied Microbiology and Biotechnology and 10 papers in Epidemiology. Recurrent topics in Alexandre Charmillon's work include Antibiotic Use and Resistance (12 papers), Antibiotics Pharmacokinetics and Efficacy (12 papers) and Bacterial Identification and Susceptibility Testing (7 papers). Alexandre Charmillon is often cited by papers focused on Antibiotic Use and Resistance (12 papers), Antibiotics Pharmacokinetics and Efficacy (12 papers) and Bacterial Identification and Susceptibility Testing (7 papers). Alexandre Charmillon collaborates with scholars based in France, Portugal and Switzerland. Alexandre Charmillon's co-authors include S Bevilacqua, Nelly Agrinier, Marc Léone, Jean Vigneron, Béatrice Demoré, Emmanuel Novy, Céline Pulcini, C. Rumeau, P. Gallet and Antoine Kimmoun and has published in prestigious journals such as SHILAP Revista de lepidopterología, Intensive Care Medicine and Journal of Antimicrobial Chemotherapy.

In The Last Decade

Alexandre Charmillon

24 papers receiving 361 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alexandre Charmillon France 10 143 114 95 60 53 28 364
Ellen Berni United Kingdom 10 31 0.2× 107 0.9× 53 0.6× 24 0.4× 11 0.2× 32 431
Michaël Thy France 10 33 0.2× 114 1.0× 30 0.3× 31 0.5× 36 0.7× 47 364
Norberto E. Soto United States 8 66 0.5× 61 0.5× 22 0.2× 18 0.3× 34 0.6× 10 496
Shen-Peng Chang Taiwan 11 62 0.4× 67 0.6× 34 0.4× 19 0.3× 57 1.1× 29 264
Lech Krawczyk Poland 10 76 0.5× 71 0.6× 71 0.7× 32 0.5× 127 2.4× 22 351
G. Neeser Germany 10 59 0.4× 295 2.6× 29 0.3× 64 1.1× 44 0.8× 22 583
Marie Attwood United Kingdom 9 79 0.6× 66 0.6× 33 0.3× 392 6.5× 100 1.9× 26 609
Kaoru Okazaki Japan 12 46 0.3× 134 1.2× 67 0.7× 9 0.1× 21 0.4× 53 488
Stylianos Karatzas Greece 7 273 1.9× 249 2.2× 45 0.5× 73 1.2× 291 5.5× 9 594
Nathalie Maes Belgium 14 50 0.3× 72 0.6× 18 0.2× 60 1.0× 29 0.5× 48 578

Countries citing papers authored by Alexandre Charmillon

Since Specialization
Citations

This map shows the geographic impact of Alexandre Charmillon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alexandre Charmillon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alexandre Charmillon more than expected).

Fields of papers citing papers by Alexandre Charmillon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alexandre Charmillon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alexandre Charmillon. The network helps show where Alexandre Charmillon may publish in the future.

Co-authorship network of co-authors of Alexandre Charmillon

This figure shows the co-authorship network connecting the top 25 collaborators of Alexandre Charmillon. A scholar is included among the top collaborators of Alexandre Charmillon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alexandre Charmillon. Alexandre Charmillon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Agrinier, Nelly, Marc Soudant, Alexandre Charmillon, et al.. (2025). Management of invasive candidiasis in French ICUs: insights from a 2024 nationwide survey. European Journal of Clinical Microbiology & Infectious Diseases. 44(8). 1977–1986.
3.
4.
Brennstuhl, Marie‐Jo, Alexandre Charmillon, Florence Meyer, et al.. (2024). Hospital antimicrobial stewardship team perceptions and usability of a computerized clinical decision support system. International Journal of Medical Informatics. 192. 105653–105653.
5.
Pape, Elise, Alexandre Charmillon, Emmanuel Novy, et al.. (2023). In vitro stability study of 10 beta‐lactam antibiotics in human plasma samples. Fundamental and Clinical Pharmacology. 38(3). 502–510. 5 indexed citations
6.
Fougnot, Sébastien, Nathalie Thilly, C. Pulcini, et al.. (2023). Impact of selective reporting of antibiotic susceptibility testing results for urinary tract infections in the outpatient setting: a prospective controlled before-after intervention study. Clinical Microbiology and Infection. 29(7). 897–903. 5 indexed citations
7.
Agrinier, Nelly, Alexandre Charmillon, Céline Pulcini, et al.. (2022). Evaluating antibiotic stewardship and healthcare-associated infections surveillance assisted by computer: protocol for an interrupted time series study. BMJ Open. 12(4). e056125–e056125. 3 indexed citations
8.
Goehringer, François, et al.. (2022). Brain 18F-FDG PET imaging in outpatients with post-COVID-19 conditions: findings and associations with clinical characteristics. European Journal of Nuclear Medicine and Molecular Imaging. 50(4). 1084–1089. 31 indexed citations
9.
Charmillon, Alexandre, Xavier Parent, Simona Pavel, et al.. (2022). Incidence, associated factors, and effect on renal function of amoxicillin crystalluria in patients receiving high doses of intravenous amoxicillin (The CRISTAMOX Study): A cohort study. EClinicalMedicine. 45. 101340–101340. 9 indexed citations
10.
Bocquier, Aurélie, Sébastien Fougnot, Joëlle Kivits, et al.. (2022). Selective reporting of antibiotic susceptibility testing results for urine cultures: feasibility and acceptability by general practitioners and laboratory professionals in France. JAC-Antimicrobial Resistance. 5(1). dlad013–dlad013. 2 indexed citations
11.
Agrinier, Nelly, Alexandre Charmillon, Nicolas Degand, et al.. (2022). Assessment of current practice for β-lactam therapeutic drug monitoring in French ICUs in 2021: a nationwide cross-sectional survey. Journal of Antimicrobial Chemotherapy. 77(10). 2650–2657. 8 indexed citations
12.
Bonnet, É., C. Chambrier, Alexandre Charmillon, et al.. (2021). Antibiotic lock therapy for the conservative treatment of long-term intravenous catheter-related infections in adults and children: When and how to proceed? Guidelines for clinical practice 2020. Infectious Diseases Now. 51(3). 236–246. 17 indexed citations
13.
Vigneron, Jean, et al.. (2021). Physicochemical stability of cefiderocol, a novel siderophore cephalosporin, in syringes at 62.5 mg/mL for continuous administration in intensive care units. European Journal of Hospital Pharmacy. 30(e1). e29–e34. 10 indexed citations
14.
Tebano, Gianpiero, Yosra Mouelhi, Veronica Zanichelli, et al.. (2020). Selective reporting of antibiotic susceptibility testing results: a promising antibiotic stewardship tool. Expert Review of Anti-infective Therapy. 18(3). 251–262. 29 indexed citations
15.
Bevilacqua, S, Alexandre Charmillon, R. Jankowski, et al.. (2020). Evolution of Olfactory Disorders in COVID‐19 Patients. The Laryngoscope. 130(11). 2667–2673. 39 indexed citations
16.
Alauzet, Corentine, et al.. (2019). Hepatic abscess due to Dialister pneumosintes - A case report. Anaerobe. 59. 35–37. 9 indexed citations
17.
Agrinier, Nelly, et al.. (2019). Implementation of antibiotic stewardship programmes in French ICUs in 2018: a nationwide cross-sectional survey. Journal of Antimicrobial Chemotherapy. 74(7). 2106–2114. 15 indexed citations
18.
Charmillon, Alexandre, Emmanuel Novy, Nelly Agrinier, et al.. (2016). The ANTIBIOPERF study: a nationwide cross-sectional survey about practices for β-lactam administration and therapeutic drug monitoring among critically ill patients in France. Clinical Microbiology and Infection. 22(7). 625–631. 53 indexed citations
19.
London, Jonathan, A. Grados, Christophe Fermé, et al.. (2014). Sarcoidosis Occurring After Lymphoma. Medicine. 93(21). e121–e121. 45 indexed citations
20.
Charmillon, Alexandre, et al.. (2014). Angioedema induced by angiotensin converting enzyme inhibitors, potentiated by m-TOR inhibitors: successful treatment with icatibant. Intensive Care Medicine. 40(6). 893–894. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ellen Berni Breakdown of academic impact, for papers by Michaël Thy Breakdown of academic impact, for papers by Norberto E. Soto Breakdown of academic impact, for papers by Shen-Peng Chang Breakdown of academic impact, for papers by Lech Krawczyk Breakdown of academic impact, for papers by G. Neeser Breakdown of academic impact, for papers by Marie Attwood Breakdown of academic impact, for papers by Kaoru Okazaki Breakdown of academic impact, for papers by Stylianos Karatzas Breakdown of academic impact, for papers by Nathalie Maes
Rankless by CCL
2026